The renin-angiotensin system in the development of salt-sensitive hypertension in animal models and humans

Pharmaceuticals

Volumn 3, Issue 4, 2010, Pages 940-960

  Rassler, Beate ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Antihypertensive treatment; Hypertension; Renin angiotensin system; Salt sensitivity

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; SODIUM CHLORIDE;

ANIMAL MODEL; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; BLOOD VESSEL INJURY; CARDIOVASCULAR FUNCTION; CAUSE OF DEATH; ESSENTIAL HYPERTENSION; FLUID BALANCE; HEART INJURY; HUMAN; HYPERTENSION; NONHUMAN; ORGAN INJURY; PATHOGENESIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SALT INTAKE; SALT LOADING; SODIUM BALANCE; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 77952119307     PISSN: None     EISSN: 14248247     Source Type: Journal    
DOI: 10.3390/ph3040940     Document Type: Review

References (162)

1. Garcia, E.A.; Newhouse, S.; Caulfield, M.J.; Munroe, P.B. Genes and Hypertension. Curr. Pharm. Des. 2003, 9, 1679-1689.
2. Weinberger, M.H. Salt sensitivity of blood pressure in humans. Hypertension 1996, 27, 481-490.
3. Frohlich, E.D.; Varagic, J. Sodium directly impairs target organ function in hypertension. Curr. Opin. Cardiol. 2005, 20, 424-429.
4. Calhoun, D.A.; Zhu, S.; Wyss, J.M.; Oparil, S. Diurnal blood pressure variation and dietary salt in spontaneously hypertensive rats. Hypertension 1994, 24, 1-7.
5. Huang, B.S.; Leenen, F.H. Brain amiloride-sensitive Phe-Met-Arg-Phe-NH(2)--gated Na(+) channels and Na(+)-induced sympathoexcitation and hypertension. Hypertension 2002, 39, 557-561.
6. Morgan, T.O.; Aubert, J.F.; Wang, Q. Sodium, angiotensin II, blood pressure and cardiac hypertrophy. Kidney Int. 1998, 54, S213-S215.
7. Labat, C.; Lacolley, P.; Lajemi, M.; de Gasparo, M.; Safar, M.E.; Benetos, A. Effects of valsartan on mechanical properties of the carotid artery in spontaneously hypertensive rats under high-salt diet. Hypertension 2001, 38, 439-443.
8. Ahn, J.; Varagic, J.; Slama, M.; Susic, D.; Frohlich, E.D. Cardiac structural and functional responses to salt loading in SHR. Am. J. Physiol. Heart Circ. Physiol. 2004, 287, H767-H772.
9. Varagic, J.; Frohlich, E.D.; Díez, J.; Susic, D.; Ahn, J.; González, A.; López, B. Myocardial fibrosis, impaired coronary hemodynamics, and biventricular dysfunction in salt-loaded SHR. Am. J. Physiol. Heart Circ. Physiol. 2006, 290, H1503-H1509.
10. Sasaki, Y.; Fujimura, M.; Furukawa, M.; Kubo, T. Sensitivity of pressor responses to central hypertonic saline is greatly enhanced even in pre-hypertensive spontaneously hypertensive rats. Neurosci. Lett. 2006, 399, 255-258.
11. Ziegelhöffer-Mihalovicova, B.; Arnold, N.; Marx, G.; Tannapfel, A.; Zimmer H.-G.; Rassler, B. Effects of salt loading and various therapies on cardiac hypertrophy and fibrosis in young spontaneously hypertensive rats. Life Sci. 2006, 79, 838-846.
12. Beeks, E.; Kessels, A.G.; Kroon, A.A.; van der Klauw, M.M.; de Leeuw, P.W. Genetic predisposition to salt-sensitivity: a systematic review. J. Hypertens. 2004, 22, 1243-1249.
13. Iwai, N.; Tsujita, Y.; Kinoshita, M. Isolation of a chromosome 1 region that contributes to high blood pressure and salt sensitivity. Hypertension 1998, 32, 636-638.
14. Ely, D.; Turner, M.; Milsted, A. Review of the Y chromosome and hypertension. Braz. J. Med.Biol. Res. 2000, 33, 679-691.
15. Aneas, I.; Rodrigues, M.V.; Pauletti, B.A.; Silva, G.J.; Carmona, R.; Cardoso, L.; Kwitek, A.E.; Jacob, H.J.; Soler, J.M.; Krieger, J.E. Congenic strains provide evidence that four mapped loci in chromosomes 2, 4, and 16 influence hypertension in the SHR. Physiol. Genomics 2009, 37, 52-57.
16. Johnson, M.D.; He, L.; Herman, D.; Wakimoto, H.; Wallace, C.A.; Zidek, V.; Mlejnek, P.; Musilova, A.; Simakova, M.; Vorlicek, J.; Kren, V.; Viklicky, O.; Qi, N.R.; Wang, J.; Seidman, C.E.; Seidman, J.; Kurtz, T.W.; Aitman, T.J.; Pravenec, M. Dissection of chromosome 18 blood pressure and salt-sensitivity quantitative trait loci in the spontaneously hypertensive rat. Hypertension 2009, 54, 639-645.
17. Johnson, A.G.; Nguyen, T.V.; Davis, D. Blood pressure is linked to salt intake and modulated by the angiotensinogen gene in normotensive and hypertensive elderly subjects. J. Hypertens. 2001, 19, 1053-1060.
18. Hiraga, H.; Oshima, T.; Watanabe, M.; Ishida, M.; Ishida, T.; Shingu, T.; Kambe, M.; Matsuura, H.; Kajiyama, G. Angiotensin I-converting enzyme gene polymorphism and salt sensitivity in essential hypertension. Hypertension 1996, 27, 569-572.
19. Poch, E.; González, D.; Giner, V.; Bragulat, E.; Coca, A.; de La Sierra, A. Molecular basis of salt sensitivity in human hypertension. Evaluation of renin-angiotensin-aldosterone system gene polymorphisms. Hypertension 2001, 38, 1204-1209.
20. Shimoike, H.; Iwai, N.; Kinoshita, M. Genetic analysis of renin gene expression in the central nervous system of spontaneously hypertensive rats. Neurosci. Lett. 1997, 221, 133-136.
21. Pamies-Andreu, E.; Ramirez-Lorca, R.; Stiefel García-Junco, P.; Muñiz-Grijalbo, O.; Vallejo-Maroto, I.; Garcia Morillo, S.; Miranda-Guisado, M.L.; Ortíz, J.V.; Carneado de la Fuente, J. Renin-angiotensin-aldosterone system and G-protein beta-3 subunit gene polymorphisms in saltsensitive essential hypertension. J. Hum. Hypertens. 2003, 17, 187-191.
22. Jose, P.A.; Eisner, G.M.; Felder, R.A. Dopamine and the kidney: a role in hypertension? Curr. Opin. Nephrol. Hypertens. 2003, 12, 189-194.
23. Cusi, D.; Barlassina, C.; Taglietti, M.V. Genetics of human arterial hypertension. J. Nephrol. 2003, 16, 609-615.
24. Manunta, P.; Ferrandi, M.; Messaggio, E.; Ferrari, P. A new antihypertensive agent that antagonizes the prohypertensive effect of endogenous ouabain and adducin. Cardiovasc. Hematol. Agents Med. Chem. 2006, 4, 61-66.
25. Takata, Y.; Yamashita, Y.; Takishita, S.; Tsuchihashi, T.; Tomita, Y.; Kimura, Y.; Koga, T.; Fujishima, M. Central and peripheral mechanisms of the enhanced hypertension following longterm salt loading in spontaneously hypertensive rats. Jpn. Circ. J. 1988, 52, 1317-1322.
26. Huang, B.S.; Leenen, F.H. Brain ouabain and angiotensin II in salt-sensitive hypertension in spontaneously hypertensive rats. Hypertension 1996, 28, 1005-1012.
27. Budzikowski, A.S.; Leenen, F.H. ANG II in median preoptic nucleus and pressor responses to CSF sodium and high sodium intake in SHR. Am. J. Physiol. Heart Circ. Physiol. 2001, 281, H1210-H1216.
28. Fang, Z.; Carlson, S.H.; Peng, N.; Wyss, J.M. Circadian rhythm of plasma sodium is disrupted in spontaneously hypertensive rats fed a high-NaCl diet. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2000, 278, R1490-R1495.
29. Huang, B.S.; van Vliet, B.N.; Leenen, F.H. Increases in CSF [Na+] precede the increases in blood pressure in Dahl S rats and SHR on a high-salt diet. Am. J. Physiol. Heart Circ. Physiol. 2004, 287, H1160-H1166.
30. Huang, B.S.; Amin, M.S.; Leenen, F.H. The central role of the brain in salt-sensitive hypertension. Curr. Opin. Cardiol. 2006, 21, 295-304.
31. Amin, M.S.; Reza, E.; Wang, H.; Leenen, F.H. Sodium transport in the choroid plexus and salt-sensitive hypertension. Hypertension 2009, 54, 860-867.
32. Bagrov, A.Y.; Shapiro, J.I.; Fedorova, O.V. Endogenous cardiotonic steroids: Physiology, pharmacology, and novel therapeutic targets. Pharmacol. Rev. 2009, 61, 9-38.
33. van Huysse, J.W. Endogenous brain Na pumps, brain ouabain-like substance and the alpha2 isoform in salt-dependent hypertension. Pathophysiology 2007, 14, 213-220.
34. van Huysse, J.W.; Hou, X. Pressor response to CSF sodium in mice: mediation by a ouabain-like substance and renin-angiotensin system in the brain. Brain Res. 2004, 1021, 219-231.
35. Fedorova, O.V.; Agalakova, N.I.; Talan, M.I.; Lakatta, E.G.; Bagrov, A.Y. Brain ouabain stimulates peripheral marinobufagenin via angiotensin II signalling in NaCl-loaded Dahl-S rats. J. Hypertens. 2005, 23, 1515-1523.
36. Takata, Y.; Yamashita, Y.; Takishita, S.; Kimura, Y.; Fujishima, M. Brain renin angiotensin system contributes to the salt-induced enhancement of hypertension in SHR. Clin. Exp. Hypertens. A. 1986, 8, 1149-1170.
37. Schelling, P.; Meyer, D.; Loos, H.E.; Speck, G.; Phillips, M.I.; Johnson, A.K.; Ganten, D. A micromethod for the measurement of renin in brain nuclei: its application in spontaneously hypertensive rats. Neuropharmacology 1982, 21, 455-463.
38. Ganten, D.; Hermann, K.; Bayer, C.; Unger, T.; Lang, R.E. Angiotensin synthesis in the brain and increased turnover in hypertensive rats. Science 1983, 221, 869-871.
39. Phillips, M.I.; Kimura, B. Converting enzyme inhibitors and brain angiotensin. J. Cardiovasc. Pharmacol. 1986, 8, S82-90.
40. Huang, B.S.; White, R.A.; Jeng, A.Y.; Leenen, F.H. Role of central nervous system aldosterone synthase and mineralocorticoid receptors in salt-induced hypertension in Dahl salt-sensitive rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009, 296, R994-R1000.
41. + in Wistar rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008, 295, R166-R172.
42. Gehlert, D.R.; Speth, R.C.; Wamsley, J.K. Quantitative autoradiography of angiotensin II receptors in the SHR brain. Peptides 1986, 7, 1021-1027.
43. Gutkind, J.S.; Kurihara, M.; Castren, E.; Saavedra, J.M. Increased concentration of angiotensin II binding sites in selected brain areas of spontaneously hypertensive rats. J. Hypertens. 1988, 6, 79-84.
44. Wright, J.W.; Sullivan, M.J.; Quirk, W.S.; Batt, C.M.; Harding, J.W. Heightened pressor effect and dipsogenicity to intracerebroventricularly applied angiotensin II and III in spontaneously hypertensive rats. J. Hypertens. Suppl. 1986, 4, S408-S411.
45. Kubo, T.; Hagiwara, Y. Angiotensin II sensitivity of anterior hypothalamic area neurons is enhanced in both spontaneously hypertensive rats and Dahl salt-sensitive rats. Neurosci. Lett. 2006, 397, 297-300.
46. Kubo, T.; Yamaguchi, H.; Tsujimura, M.; Hagiwara, Y.; Fukumori, R. An angiotensin system in the anterior hypothalamic area anterior is involved in the maintenance of hypertension in spontaneously hypertensive rats. Brain Res. Bull. 2000, 52, 291-296.
47. Huang, B.S.; Wang, H.; Leenen, F.H. Chronic central infusion of aldosterone leads to sympathetic hyperreactivity and hypertension in Dahl S but not Dahl R rats. Am. J. Physiol. Heart Circ. Physiol. 2005, 288, H517-H524.
48. Gomez-Sanchez, E.P.; Fort, C.; Thwaites, D. Central mineralocorticoid receptor antagonism blocks hypertension in Dahl S/JR rats. Am. J. Physiol. Endocrinol. Metab. 1992, 262, E96-E99.
49. Gomez-Sanchez, E.P.; Gomez-Sanchez, C.E. Effect of central infusion of benzamil on Dahl S rat hypertension. Am. J. Physiol. Heart Circ. Physiol. 1995; 269, H1044-H1047.
50. Lon, S.; Szczepanska-Sadowska, E.; Szczypaczewska, M. Evidence that centrally released arginine vasopressin is involved in central pressor action of angiotensin II. Am. J. Physiol. Heart Circ. Physiol. 1996, 270, H167-H173.
51. Wyss, J.M.; Mozaffari, M.S.; Roysommuti, S. Contribution of the sympathetic nervous system to salt-sensitivity in lifetime captopril-treated spontaneously hypertensive rats. J. Hypertens. 1995, 13, 1037-1042.
52. Budzikowski, A.S.; Leenen, F.H. Brain 'ouabain' in the median preoptic nucleus mediates sodium-sensitive hypertension in spontaneously hypertensive rats. Hypertension 1997, 29, 599-605.
53. Budzikowski, A.S.; Huang, B.S.; Leenen, F.H. Brain ouabain, a neurosteroid, mediates sympathetic hyperactivity in salt-sensitive hypertension. Clin. Exp. Hypertens. 1998, 20, 119-140.
54. van Huysse, J.W.; Leenen, F.H. Role of endogenous brain ouabain in the sympathoexcitatory and pressor effects of sodium. Clin. Exp. Hypertens. 1998, 20, 657-667.
55. Ono, A.; Kuwaki, T.; Kumada, M.; Fujita, T. Differential central modulation of the baroreflex by salt loading in normotensive and spontaneously hypertensive rats. Hypertension 1997, 29, 808-814.
56. Huang, B.S.; Leenen, F.H. Brain 'ouabain,' sodium, and arterial baroreflex in spontaneously hypertensive rats. Hypertension 1995, 25, 814-817.
57. Wang, W. Chronic administration of aldosterone depresses baroreceptor reflex function in the dog. Hypertension 1994, 24, 571-575.
58. Yee, K.M.; Struthers, A.D. Endogenous angiotensin II and baroreceptor dysfunction: a comparative study of losartan and enalapril in man. Br. J. Clin. Pharmacol. 1998, 46, 583-588.
59. McMullan, S.; Goodchild, A.K.; Pilowsky, P.M. Circulating angiotensin II attenuates the sympathetic baroreflex by reducing the barosensitivity of medullary cardiovascular neurones in the rat. J. Physiol. 2007, 582, 711-722.
60. Ylitalo, A.; Airaksinen, K.E.; Hautanen, A.; Kupari, M.; Carson, M.; Virolainen, J.; Savolainen, M.; Kauma, H.; Kesäniemi, Y.A.; White, P.C.; Huikuri, H.V. Baroreflex sensitivity and variants of the renin angiotensin system genes. J. Am. Coll. Cardiol. 2000, 35, 194-200.
61. Coruzzi, P.; Parati, G.; Brambilla, L.; Brambilla, V.; Gualerzi, M.; Novarini, A.; Castiglioni, P.; di Rienzo, M. Effects of salt sensitivity on neural cardiovascular regulation in essential hypertension. Hypertension 2005, 46, 1321-1326.
62. + channels prevents sympathetic hyperactivity and improves cardiac function in rats post-MI. Am. J. Physiol. Heart Circ. Physiol. 2005, 288, H2491-H2497.
63. Chan, J.Y.; Wang, L.L.; Wu, K.L.; Chan, S.H. Reduced functional expression and molecular synthesis of inducible nitric oxide synthase in rostral ventrolateral medulla of spontaneously hypertensive rats. Circulation 2001, 104, 1676-1681.
64. Dahl, L.K.; Heine, M. Primary role of renal homografts in setting chronic blood pressure levels in rats. Circ. Res. 1975, 36, 692-696.
65. Kawabe, K.; Watanabe, T.X.; Shiono, K.; Sokabe, H. Influence on blood pressure of renal isografts between spontaneously hypertensive and normotensive rats, utilizing the F1 hybrids. Jpn. Heart J. 1978, 19, 886-894.
66. de Wardener, H.E.; Mac Gregor, G.A. The natriuretic hormone and essential hypertension. The Lancet 1982, 319, 1450-1454.
67. Keller, G.; Zimmer, G.; Mall, G.; Ritz, E.; Amann, K. Nephron number in patients with primary hypertension. N. Engl. J. Med. 2003, 348, 101-108.
68. Skov, K.; Nyengaard, J.R.; Korsgaard, N.; Mulvany, M.J. Number and size of renal glomeruli in pontaneously hypertensive rats. J. Hypertens. 1994, 12, 1373-1376.
69. Fogelgren, B.; Yang, S.; Sharp, I.C.; Huckstep, O.J.; Ma, W.; Somponpun, S.J.; Carlson, E.C.; Uyehara, C.F.T.; Lozanoff, S. Deficiency in Six2 during prenatal development is associated with reduced nephron number, chronic renal failure, and hypertension in Br/+ adult mice. Am. J. Physiol. Renal Physiol. 2009, 296, F1166-F1178.
70. Barker, D.J.; Osmond, C.; Golding, J.; Kuh, D.; Wadsworth, M.E. Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. BMJ 1989, 298, 564-567.
71. Zandi-Nejad, K.; Luyckx, V.A.; Brenner, B.M. Adult Hypertension and Kidney Disease. The Role of Fetal Programming. Hypertension 2006, 47, 502-508.
72. Marin, E.C.; Balbi, A.P.; Francescato, H.D.; Alves da Silva, C.G.; Costa, R.S.; Coimbra, T.M. Renal structure and function evaluation of rats from dams that received increased sodium intake during pregnancy and lactation submitted or not to 5/6 nephrectomy. Ren. Fail. 2008, 30, 547-555.
73. Johnson, R.J.; Schreiner, G.F. Hypothesis: the role of acquired tubulointerstitial disease in the pathogenesis of salt-dependent hypertension. Kidney Int. 1997, 52, 1169-1179.
74. Ray, P.E.; Suga, S.; Liu, X.H.; Huang, X.; Johnson, R.J. Chronic potassium depletion induces renal injury, salt sensitivity, and hypertension in young rats. Kidney Int. 2001, 59, 1850-1858.
75. Kurokawa, K. Role of the kidney in the genesis of hypertension: aberrant renal response to excess salt intake. Clin. Exp. Pharmacol. Physiol. 1995, 22, S417-S422.
76. Persson, A.E.; Gutierrez, A.; Pittner, J.; Ring, A.; Ollerstam, A.; Brown, R.; Liu, R.; Thorup, C. Renal NO production and the development of hypertension. Acta Physiol. Scand. 2000, 168, 169-174.
77. Oparil, S. The sympathetic nervous system in clinical and experimental hypertension. Kidney Int. 1986, 30, 437-352.
78. Sato, Y.; Ando, K.; Ogata, E.; Fujita, T. High-potassium diet attenuates salt-induced acceleration of hypertension in SHR. Am. J. Physiol. 1991, 260, R21-R26.
79. Wyss, J.M.; Oparil, S.; Sripairojthikoon, W. Neuronal control of the kidney: contribution to hypertension. Can. J. Physiol. Pharmacol. 1992, 70, 759-770.
80. Pedrino, G.R.; Rosa, D.A.; Korim, W.S.; Cravo, S.L. Renal sympathoinhibition induced by hypernatremia: involvement of A1 noradrenergic neurons. Auton. Neurosci. 2008, 142, 55-63.
81. Esler, M.; Lambert, G.; Brunner-La Rocca, H.P.; Vaddadi, G.; Kaye, D. Sympathetic nerve activity and neurotransmitter release in humans: translation from pathophysiology into clinical practice. Acta Physiol. Scand. 2003, 177, 275-284.
82. Judy, W.V.; Farrell, S.K. Arterial baroreceptor reflex control of sympathetic nerve activity in the spontaneously hypertensive rat. Hypertension 1979, 1, 605-614.
83. Caplea, A.; Seachrist, D.; Daneshvar, H.; Dunphy, G.; Ely, D. Noradrenergic content and turnover rate in kidney and heart shows gender and strain differences. J. Appl. Physiol. 2002, 92, 567-571.
84. Guadagnini, D.; Gontijo, J.A. Altered renal sodium handling in spontaneously hypertensive rats (SHR) after hypertonic saline intracerebroventricular injection: role of renal nerves. Life Sci. 2006, 79, 1666-1673.
85. + in 2 congenic strains of Dahl salt-sensitive rats. Hypertension 2007, 49, 1315-1320.
86. Greenberg, S.; Osborn, J.L. Relationship between sodium balance and renal innervation during hypertension development in the spontaneously hypertensive rat. J. Hypertens. 1994, 12, 1359-1364.
87. Grisk, O.; Rose, H.-J.; Lorenz, G.; Rettig, R. Sympathetic-renal interaction in chronic arterial pressure control. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2002, 283, R441-R450.
88. + ATPase to inhibition by dopamine in spontaneous hypertensive and Wistar-Kyoto rats. Clin. Exp. Hypertens. 2000, 22, 455-469.
89. Zeng, C.; Luo, Y.; Asico, L.D.; Hopfer, U.; Eisner, G.M.; Felder, R.A.; Jose, P.A. Perturbation of D1 dopamine and AT1 receptor interaction in spontaneously hypertensive rats. Hypertension 2003, 42, 787-792.
90. Zeng, C.; Wang, Z.; Hopfer, U.; Asico, L.D.; Eisner, G.M.; Felder, R.A.; Jose, P.A. Rat strain effects of AT1 receptor activation on D1 dopamine receptors in immortalized renal proximal tubule cells. Hypertension 2005, 46, 799-805.
91. Iimura, O.; Shimamoto, K. Salt and hypertension: water-sodium handling in essential hypertension. Ann. N. Y. Acad. Sci. 1993, 676, 105-121.
92. Katori, M.; Majima, M. The renal kallikrein-kinin system: its role as a safety valve for excess sodium intake, and its attenuation as a possible etiologic factor in salt-sensitive hypertension. Crit. Rev. Clin. Lab. Sci. 2003, 40, 43-115.
93. Bagrov, A.Y.; Fedorova, O.V. Cardenolide and bufadienolide ligands of the sodium pump. How they work together in NaCl sensitive hypertension. Front. Biosci. 2005, 10, 2250-2256.
94. Blaustein, M.P.; Hamlyn, J.M. Role of a natriuretic factor in essential hypertension: an hypothesis. Ann. Intern. Med. 1983, 98, 785-792.
95. de Wardener, H.E.; Mac Gregor, G.A. The relation of the natriuretic hormone to essential hypertension. Postgrad. Med. J. 1983, 59, 74-77.
96. Ferrari, P.; Ferrandi, M.; Valentini, G.; Manunta, P.; Bianchi, G. Targeting Ouabain- and Adducin-dependent mechanisms of hypertension and cardiovascular remodeling as a novel pharmacological approach. Med. Hypotheses 2007, 68, 1307-1314.
97. Manunta, P.; Hamilton, B.P.; Hamlyn, J.M. Salt intake and depletion increase circulating levels of endogenous ouabain in normal men. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006, 290, R553-R559.
98. Dostanic, I.; Paul, R.J.; Lorenz, J.N.; Theriault, S.; van Huysse, J.W.; Lingrel, J.B. The alpha2-isoform of Na-K-ATPase mediates ouabain-induced hypertension in mice and increased vascular contractility in vitro. Am. J. Physiol. Heart Circ. Physiol. 2005, 288, H477-H485.
99. Zhang, J.; Lee, M.Y.; Cavalli, M.; Chen, L.; Berra-Romani, R.; Balke, C.W.; Bianchi, G.; Ferrari, P.; Hamlyn, J.M.; Iwamoto, T.; Lingrel, J.B.; Matteson, D.R.; Wier, W.G.; Blaustein, M.P. Sodium pump alpha2 subunits control myogenic tone and blood pressure in mice. J. Physiol. 2005, 569, 243-256.
100. Blaustein, M.P.; Zhang, J.; Chen, L.; Song, H.; Raina, H.; Kinsey, S.P.; Izuka, M.; Iwamoto, T.; Kotlikoff, M.I.; Lingrel, J.B.; Philipson, K.D.; Wier, W.G.; Hamlyn, J.M. The pump, the exchanger, and endogenous ouabain: signaling mechanisms that link salt retention to hypertension. Hypertension 2009, 53, 291-298.
101. Cusi, D.; Barlassina, C.; Azzani, T.; Casari, G.; Citterio, L.; Devoto, M.; Glorioso, N.; Lanzani, C.; Manunta, P.; Righetti, M.; Rivera, R.; Stella, P.; Troffa, C.; Zagato, L.; Bianchi, G. Polymorphisms of alpha-adducin and salt sensitivity in patients with essential hypertension. Lancet 1997, 349 (9062), 1353-1357.
102. +- ATPase: relation to genetic hypertension. Am. J. Physiol. Heart Circ. Physiol. 1999, 277, H1338-H1349.
103. Wang, J.G.; Staessen, J.A.; Messaggio, E.; Nawrot, T.; Fagard, R.; Hamlyn, J.M.; Bianchi, G.; Manunta, P. Salt, endogenous ouabain and blood pressure interactions in the general population. J. Hypertens. 2003, 21, 1475-1481.
104. Manunta, P.; Maillard, M.; Tantardini, C.; Simonini, M.; Lanzani, C.; Citterio, L.; Stella, P.; Casamassima, N.; Burnier, M.; Hamlyn, J.M.; Bianchi, G. Relationships among endogenous ouabain, alpha-adducin polymorphisms and renal sodium handling in primary hypertension. J. Hypertens. 2008, 26, 914-920.
105. Fedorova, O.V.; Kolodkin, N.I.; Agalakova, N.I.; Lakatta, E.G.; Bagrov, A.Y. Marinobufagenin, an endogenous alpha-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats. Hypertension 2001, 37, 462-466.
106. Fedorova, O.V.; Talan, M.I.; Agalakova, N.I.; Lakatta, E.G.; Bagrov, A.Y. Endogenous ligand of alpha(1) sodium pump, marinobufagenin, is a novel mediator of sodium chloride--dependent hypertension. Circulation 2002, 105, 1122-1127.
107. Bagrov, A.Y.; Shapiro, J.I. Endogenous digitalis: pathophysiologic roles and therapeutic applications. Nat. Clin. Pract. Nephrol. 2008, 4, 378-392.
108. Anderson, D.E.; Fedorova, O.V.; Morrell, C.H.; Longo, D.L.; Kashkin, V.A.; Metzler, J.D.; Bagrov, A.Y.; Lakatta, E.G. Endogenous sodium pump inhibitors and age-associated increases in salt sensitivity of blood pressure in normotensives. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008, 294, R1248-R1254.
109. Fedorova, O.V.; Zhuravin, I.A.; Agalakova, N.I.; Yamova, L.A.; Talan, M.I.; Lakatta, E.G.; Bagrov, A.Y. Intrahippocampal microinjection of an exquisitely low dose of ouabain mimics NaCl loading and stimulates a bufadienolide Na/K-ATPase inhibitor. J. Hypertens. 2007, 25, 1834-1844.
110. Smallegange, C.; Kline, R.L.; Adams, M.A. Transplantation of enalapril-treated kidneys confers persistent lowering of arterial pressure in SHR. Hypertension 2003, 42, 932-936.
111. Hodge, G.; Ye, V.Z.; Duggan, K.A. Dysregulation of angiotensin II synthesis is associated with salt sensitivity in the spontaneous hypertensive rat. Acta Physiol. Scand. 2002, 174, 209-215.
112. Meng, Q.C.; Durand, J.; Chen, Y.F.; Oparil, S. Effects of dietary salt on angiotensin peptides in kidney. J. Am. Soc. Nephrol. 1995, 6, 1209-1215.
113. Mizutani, S.; Ishii, M.; Hattori, A.; Nomura, S.; Numaguchi, Y.; Tsujimoto, M.; Kobayshi, H.; Murohara, T.; Wright, J. W. New insights into the importance of aminopeptidase A in hypertension. Heart Fail. Rev. 2008, 13, 273-284.
114. Pak, C.H. Plasma adrenaline and noradrenaline concentrations of the spontaneously hypertensive rat. Jpn. Heart J. 1981, 22, 987-995.
115. Tsunoda, M.; Takezawa, K.; Santa, T.; Ina, Y.; Nagashima, K.; Ohmori, K.; Kobayashi, S.; Imai, K. New approach for measurement of sympathetic nervous abnormality in conscious, spontaneously hypertensive rats. Jpn. J. Pharmacol. 2000, 83, 39-45.
116. Lee, R.M.; Triggle, C.R.; Cheung, D.W.; Coughlin, M.D. Structural and functional consequence of neonatal sympathectomy on the blood vessels of spontaneously hypertensive rats. Hypertension 1987, 10, 328-338.
117. Sofola, O.A.; Knill, A.; Hainsworth, R.; Drinkhill, M. Change in endothelial function in mesenteric arteries of Sprague-Dawley rats fed a high salt diet. J. Physiol. 2002, 543, 255-260.
118. Rossoni, L.V.; Cunha, V.; Franca, A.; Vassallo, D.V. The influence of nanomolar ouabain on vascular pressor responses is modulated by the endothelium. J. Cardiovasc. Pharmacol. 1999, 34, 887-892.
119. Padilha, A.S.; Rossoni, L.V.; Xavier, F.E.; Vassallo, D.V. Ouabain at nanomolar concentration promotes synthesis and release of angiotensin II from the endothelium of the tail vascular bed of spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. 2004, 44, 372-380.
120. Schwarz, P.; Diem, R.; Dun, N.J.; Förstermann, U. Endogenous and exogenous nitric oxide inhibits norepinephrine release from rat heart sympathetic nerves. Circ. Res. 1995, 77, 841-848.
121. Vo, P.A.; Reid, J.J.; Rand, M.J. Attenuation of vasoconstriction by endogenous nitric oxide in rat caudal artery. Br. J. Pharmacol. 1992, 107, 1121-1128.
122. Costa, F.; Christensen, N.J.; Farley, G.; Biaggioni, I. NO modulates norepinephrine release in human skeletal muscle: implications for neural preconditioning. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2001, 280, R1494-R1498.
123. Patil, R.D.; di Carlo, S.E.; Collins, H.L. Acute exercise enhances nitric oxide modulation of vascular response to phenylephrine. Am. J. Physiol. 1993, 265, H1184-H1188.
124. Toda, N.; Kitamura, Y.; Okamura, T. Neural mechanism of hypertension by nitric oxide synthase inhibitor in dogs. Hypertension 1993, 21, 3-8.
125. Ni, Z.; Oveisi, F.; Vaziri, N.D. Nitric Oxide Synthase Isotype Expression in Salt-Sensitive and Salt-Resistant Dahl Rats. Hypertension 1999, 34, 552-557.
126. Fujiwara, N.; Osanai, T.; Kamada, T.; Katoh, T.; Takahashi, K.; Okumura, K. Study on the Relationship Between Plasma Nitrite and Nitrate Level and Salt Sensitivity in Human Hypertension. Modulation of Nitric Oxide Synthesis by Salt Intake. Circulation 2000, 101, 856-861.
127. Iaccarino, G.; Ciccarelli, M.; Sorriento, D.; Cipolletta, E.; Cerullo, V.; Iovino, G.L.; Paudice, A.; Elia, A.; Santulli, G.; Campanile, A.; Arcucci, O.; Pastore, L.; Salvatore, F.; Condorelli, G.; Trimarco, B. AKT participates in endothelial dysfunction in hypertension. Circulation 2004, 109, 2587-2593.
128. Hare, J.M.; Loh, E.; Creager, M.A.; Colucci, W.S. Nitric oxide inhibits the positive inotropic response to beta-adrenergic stimulation in humans with left ventricular dysfunction. Circulation 1995, 92, 2198-2203.
129. 2+ exchanger type-1 in vascular smooth muscle. Nat. Med. 2004, 10, 1193-1199.
130. Kramer, H.J.; Glanzer, K.; Sorger, M. The role of endogenous inhibition of Na-K-ATPase in human hypertension--sodium pump activity as a determinant of peripheral vascular resistance. Clin. Exp. Hypertens. A 1985, 7, 769-782.
131. Laredo, J.; Shah, J.R.; Lu, Z.; Hamilton, B.P.; Hamlyn, J.M. Angiotensin II Stimulates Secretion of Endogenous Ouabain From Bovine Adrenocortical Cells via Angiotensin Type 2 Receptors. Hypertension 1997, 29, 401-407.
132. Hamlyn, J.M.; Hamilton, B.P.; Manunta, P. Endogenous ouabain, sodium balance and blood pressure: a review and a hypothesis. J. Hypertens. 1996, 14, 151-167.
133. Hu, W.Y.; Fukuda, N.; Kanmatsuse, K. Growth characteristics, angiotensin II generation, and microarray-determined gene expression in vascular smooth muscle cells from young spontaneously hypertensive rats. J. Hypertens. 2002, 20, 1323-1333.
134. Puddu, P.; Puddu, G.M.; Zaca, F.; Muscari, A. Endothelial dysfunction in hypertension. Acta Cardiol. 2000, 55, 221-232.
135. Moreau, P.; d'Uscio, L.V.; Shaw, S.; Takase, H.; Barton, M.; Lüscher, T.F. Angiotensin II increases tissue endothelin and induces vascular hypertrophy - Reversal by ETA-receptor antagonist. Circulation 1997, 96, 1593-1597.
136. Ortiz, M.C.; Manriquez, M.C.; Romero, J.C.; Juncos, L.A. Antioxidants block angiotensin II- induced increases in blood pressure and endothelin. Hypertension 2001, 38, 655-659.
137. Zerrouk, A.; Auguet, M.; Chabrier, P.-E. Augmented endothelium-dependent contraction to angiotensin II in the SHR aorta: Role of an inducible cyclooxygenase metabolite. J. Cardiovasc. Pharmacol. 1998, 31, 525-533.
138. Sasser, J.M.; Pollock, J.S.; Pollock, D.M. Renal endothelin in chronic angiotensin II hypertension. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2002, 283, R243-R248.
139. Goto, K.; Fujii, K.; Onaka, U.; Abe, I.; Fujishima, M. Renin-Angiotensin System Blockade Improves Endothelial Dysfunction in Hypertension. Hypertension 2000, 36, 575-580.
140. Cai, H.; Li, Z.; Dikalov, S.; Holland, S.M.; Hwang, J.; Jo, H.; Dudley, S.C. Jr.; Harrison, D.G. NAD(P)H oxidase-derived hydrogen peroxide mediates endothelial nitric oxide production in response to angiotensin II. J. Biol. Chem. 2002, 277, 48311-48317.
141. Landmesser, U.; Cai, H.; Dikalov, S.; McCann, L.; Hwang, J.; Jo, H.; Holland, S.M.; Harrison, D.G. Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension 2002, 40, 511-515.
142. Mollnau, H.; Wendt, M.; Szöcs, K.; Lassègue, B.; Schulz, E.; Oelze, M.; Li, H.; Bodenschatz, M.; August, M.; Kleschyov, A.L.; Tsilimingas, N.; Walter, U.; Förstermann, U.; Meinertz, T.; Griendling, K.; Münzel, T. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ. Res. 2002, 90, E58-E65.
143. Touyz, R.M.; Schiffrin, E.L. Increased generation of superoxide by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients: role of phospholipase D-dependent NAD(P)H oxidase-sensitive pathways. J. Hypertens. 2001, 19, 1245-1254.
144. Rueckschloss, U.; Quinn, M.T.; Holtz, J.; Morawietz, H. Dose-dependent regulation of NAD(P)H oxidase expression by angiotensin II in human endothelial cells: protective effect of angiotensin II type 1 receptor blockade in patients with coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 2002, 22, 1845-1851.
145. Lassègue, B.; Clempus, R.E. Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003, 285, R277-R297.
146. Touyz, R.M.; Tabet, F.; Schiffrin, E.L. Redox-dependent signalling by angiotensin II and vascular remodelling in hypertension. Clin. Exp. Pharmacol. Physiol. 2003, 30, 860-866.
147. Matsui, H.; Ando, K.; Kawarazaki, H.; Nagae, A.; Fujita, M.; Shimosawa, T.; Nagase, M.; Fujita, T. Salt excess causes left ventricular diastolic dysfunction in rats with metabolic disorder. Hypertension 2008, 52, 287-294.
148. Matsui, H.; Barry, W.H.; Livsey, C.; Spitzer, K.W. Angiotensin II stimulates sodium-hydrogen exchange in adult rabbit ventricular myocytes. Cardiovasc. Res. 1995, 29, 215-221.
149. + antiport, protein kinase C trio in essential hypertension. Am. J. Hypertens. 1994, 7, 205-212.
150. Schiffrin, E.L.; Park, J.B.; Intengan, H.D.; Touyz, R.M. Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan. Circulation 2000, 101, 1653-1659.
151. de Resende, M.M.; Mill, J.G. Effect of high salt intake on local renin-angiotensin system and ventricular dysfunction following myocardial infarction in rats. Clin. Exp. Pharmacol. Physiol. 2007, 34, 274-279.
152. Liang, B.; Leenen, F.H. Prevention of salt-induced hypertension and fibrosis by AT1-receptor blockers in Dahl S rats. J. Cardiovasc. Pharmacol. 2008, 51, 457-466.
153. Liang, B.; Leenen, F.H. Prevention of salt induced hypertension and fibrosis by angiotensin converting enzyme inhibitors in Dahl S rats. Br. J. Pharmacol. 2007, 152, 903-914.
154. Linz, W.; Schölkens, B.A.; Ganten, D. Converting Enzyme Inhibition Specifically Prevents the Development and Induces Regression of Cardiac Hypertrophy in Rats. Clin. Exp. Hypertens. 1989, 11, 1325-1350.
155. Frohlich, E.D. Left ventricular hypertrophy: dissociation of structural and functional effects by therapy. Adv. Exp. Med. Biol. 1991, 308, 175-190.
156. Biagini, G.; Zoli, M.; Torri, C.; Boschi, S.; Vantaggiato, G.; Ballestri, M.; Baraldi, A.; Agnati, L. F. Protective effects of delapril, indapamide and their combination chronically administered to stroke-prone spontaneously hypertensive rats fed a high-sodium diet. Clin. Sci. (Lond.) 1997, 93, 401-411.
157. Migdalof, B.H.; Antonaccio, M.J.; McKinstry, D.N.; Singhvi, S.M.; Lan, S.J.; Egli, P.; Kripalani, K.J. Captopril: pharmacology, metabolism and disposition. Drug Metab. Rev. 1984, 15, 841-869.
158. Inada, Y.; Tanabe, M.; Shibouta, Y.; Kawazoe, K.; Nishikawa, K.; Kikuchi, S. Antihypertensive action of a non-sulfhydryl angiotensin converting enzyme inhibitor (CV-3317) in various hypertensive models. Jpn. J. Pharmacol. 1986, 42, 1-8.
159. Dunn, F.G.; Oigman, W.; Ventura, H.O.; Messerli, F.H.; Kobrin, I.; Frohlich, E.D. Enalapril improves systemic and renal hemodynamics and allows regression of left ventricular mass in essential hypertension. Am. J. Cardiol. 1984, 53, 105-108.
160. di Nicolantonio, R. Failure of captopril to lower blood pressure in spontaneously hypertensive rats offered water and saline to drink. Clin. Exp. Pharmacol. Physiol. 1983, 10, 269-272.
161. Fliser, D.; Nowack, R.; Wolf, G.; Ritz, E. Differential effects of ACE inhibitors and vasodilators on renal function curve in patients with primary hypertension. Blood Press. 1993, 2, 296-300.
162. Bouaziz, H.; Joulin, Y.; Safar, M.; Benetos, A. Effects of bradykinin B2 receptor antagonism on the hypotensive effects of ACE inhibition. Br. J. Pharmacol. 1994, 113, 717-722.